Search results
Results from the WOW.Com Content Network
A schistosomicide is a drug used to combat schistosomiasis. [1] List. Examples listed in MeSH include: [2] amoscanate; arteether; artemether; chloroxylenol; hycanthone;
Gnathostoma spinigerum is a parasitic nematode that causes gnathostomiasis in humans, also known as its clinical manifestations are creeping eruption, larva migrans, Yangtze edema, Choko-Fuschu Tua chid and wandering swelling. [citation needed] Gnathostomiasis in animals can be serious, and even
Gnathostomiasis, also known as larva migrans profundus, [2]: 436 is the human infection caused by the nematode Gnathostoma spinigerum and/or Gnathostoma hispidum, which infects vertebrates. Symptoms and signs
The most common incident of gnathostomiasis is found in Japan and Thailand due to the consumption of flesh loaches. [2] This is partly caused by the loach-fish contaminated with infective larvae of Gnathostoma that some Japanese gourmets like to eat live. These fish have mainly been imported from other Asian countries. [2]
Praziquantel is in the anthelmintic class of medications. [3] It works partly by affecting the function of the worm's sucker. [3] Praziquantel was approved for medical use in the United States in 1982. [3] It is on the World Health Organization's List of Essential Medicines. [5]
Some drugs may be legally classified as over-the-counter (i.e. no prescription is required), but may only be dispensed by a pharmacist after an assessment of the patient's needs or the provision of patient education. Regulations detailing the establishments where drugs may be sold, who is authorized to dispense them, and whether a prescription ...
This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales.
Between 1975 and 1999 only 13 of 1,300 new drugs were antiparasitics, which raised concerns that insufficient incentives existed to drive development of new treatments for diseases that disproportionately target low-income countries.